Steer Health, a leading provider of AI-powered healthcare solutions, announced today that it was recognized in…
Category: Health care @IT
Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium
mmunovia (NASDAQ STOCKHOLM: IMMNOV), the pancreatic cancer diagnostics company, will present an update on its next-generation test…
XP Health secures impactful partnerships with Employee Navigator and Bennie on the heels of major Series B funding
XP Health, a company dedicated to modernizing vision care with a digital-first vision, announced two key partnerships…
Ocutrx Unveils DigiLoupes™ Headset with Advanced AR, XR, and Pancake Lens Technology for Medical and Surgical Applications
Ocutrx Technologies, Inc. (“Ocutrx”), a leader in augmented reality (AR) and 3D technology for medical, enterprise, and…
Product Launch: Modius Sleep FDA-Cleared Non-Invasive Device that Treats Chronic Insomnia is Now Available for Purchase
Neurovalens, a global health-tech leader in neurotechnology, has launched its first product, Modius Sleep, to treat…
Bone Health and Osteoporosis Foundation (BHOF) Awarded Multi-Year Grant to Increase Bone Health Awareness from the Centers for Disease Control and Prevention (CDC)
he Bone Health and Osteoporosis Foundation announced that it has been awarded a major three-year grant…
RxPreferred Revolutionizes Healthcare Affordability with Launch of AI-Based Savings Program, Rx-Performance
RxPreferred, a leading pharmacy benefits administrator and advocate for transparent, cost-effective healthcare solutions, continues its push…
L.A. Care and Health Net Commit $90 Million to Launch Two Innovative Health Care Programs to Support Those Experiencing Homelessness in L.A. County
The Health Plans Have Launched a New Care Coordination Model for Their 85,000+ Members Who Lack…
Cardinal Health celebrates Greenville, South Carolina, distribution center opening
‘Warehouse of the Future’ to expand nationwide distribution network in support of home healthcare growth.’ DUBLIN,…
European Commission Approves Astellas’ PADCEV™ (enfortumab vedotin) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Urothelial Cancer
– First regimen approved in advanced urothelial cancer to demonstrate superiority to platinum-containing chemotherapy, the standard…